Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Siga Technologies Gross Margin 2011-2025 | SIGA

Current and historical gross margin for Siga Technologies (SIGA) over the last 10 years. The current gross profit margin for Siga Technologies as of June 30, 2025 is %.
Siga Technologies Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-06-30 $0.18B $0.14B 77.09%
2025-03-31 $0.12B $0.09B 75.83%
2024-12-31 $0.14B $0.11B 76.81%
2024-09-30 $0.17B $0.14B 81.50%
2024-06-30 $0.17B $0.14B 81.98%
2024-03-31 $0.16B $0.14B 87.82%
2023-12-31 $0.14B $0.12B 87.77%
2023-09-30 $0.03B $0.03B 88.24%
2023-06-30 $0.10B $0.09B 92.78%
2023-03-31 $0.11B $0.10B 93.52%
2022-12-31 $0.11B $0.10B 90.09%
2022-09-30 $0.22B $0.19B 88.37%
2022-06-30 $0.15B $0.13B 85.81%
2022-03-31 $0.14B $0.12B 85.00%
2021-12-31 $0.13B $0.12B 88.06%
2021-09-30 $0.06B $0.05B 89.47%
2021-06-30 $0.10B $0.09B 88.54%
2021-03-31 $0.13B $0.11B 88.98%
2020-12-31 $0.13B $0.11B 88.80%
2020-09-30 $0.09B $0.08B 90.11%
2020-06-30 $0.06B $0.05B 90.91%
2020-03-31 $0.02B $0.02B 94.74%
2019-12-31 $0.03B $0.03B 96.15%
2019-09-30 $0.02B $0.02B 91.67%
2019-06-30 $0.49B $0.39B 80.29%
2019-03-31 $0.49B $0.39B 80.25%
2018-12-31 $0.48B $0.38B 79.92%
2018-09-30 $0.48B $0.38B 80.08%
2018-06-30 $0.01B $0.01B 100.00%
2018-03-31 $0.01B $0.01B 100.00%
2017-12-31 $0.01B $0.01B 100.00%
2017-09-30 $0.02B $0.02B 100.00%
2017-06-30 $0.02B $0.02B 100.00%
2017-03-31 $0.02B $0.02B 100.00%
2016-12-31 $0.02B $0.02B 100.00%
2016-09-30 $0.01B $0.01B 100.00%
2016-06-30 $0.01B $0.01B 100.00%
2016-03-31 $0.01B $0.01B 100.00%
2015-12-31 $0.01B $0.01B 100.00%
2015-09-30 $0.00B $0.00B 100.00%
2015-06-30 $0.00B $0.00B 100.00%
2015-03-31 $0.00B $0.00B 100.00%
2014-12-31 $0.00B $0.00B 100.00%
2014-09-30 $0.00B $0.00B 100.00%
2014-06-30 $0.01B $0.01B 100.00%
2014-03-31 $0.01B $0.01B 100.00%
2013-12-31 $0.01B $0.01B 100.00%
2013-09-30 $0.01B $0.01B 100.00%
2013-06-30 $0.01B $0.01B 100.00%
2013-03-31 $0.01B $0.01B 100.00%
2012-12-31 $0.01B $0.01B 100.00%
2012-09-30 $0.01B $0.01B 100.00%
2012-06-30 $0.01B $0.01B 100.00%
2012-03-31 $0.01B $0.01B 100.00%
2011-12-31 $0.01B $0.01B 100.00%
2011-09-30 $0.01B $0.01B 100.00%
2011-06-30 $0.01B $0.01B 100.00%
2011-03-31 $0.02B $0.02B 100.00%
2010-12-31 $0.02B $0.02B 100.00%
2010-09-30 $0.02B $0.02B 100.00%
2010-06-30 $0.02B $0.02B 100.00%
2010-03-31 $0.02B $0.02B 100.00%
2009-12-31 $0.01B $0.01B 100.00%
2009-09-30 $0.01B $0.01B 100.00%
2009-06-30 $0.01B $0.01B 100.00%
2009-03-31 $0.01B $0.01B 100.00%
2008-12-31 $0.01B $0.01B 100.00%
2008-09-30 $0.01B $0.01B 100.00%
2008-06-30 $0.01B $0.01B 100.00%
2008-03-31 $0.01B $0.01B 100.00%
2007-12-31 $0.01B $0.01B 100.00%
2007-09-30 $0.01B $0.01B 100.00%
2007-06-30 $0.01B $0.01B 100.00%
2007-03-31 $0.01B $0.01B 100.00%
2006-12-31 $0.01B $0.01B 100.00%
2006-09-30 $0.01B $0.01B 100.00%
2006-06-30 $0.01B $0.01B 100.00%
2006-03-31 $0.01B $0.01B 100.00%
2005-12-31 $0.01B $0.01B 100.00%
2005-09-30 $0.01B $0.01B 100.00%
2005-06-30 $0.01B $0.01B 100.00%
2005-03-31 $0.00B $0.00B 100.00%
2004-12-31 $0.00B $0.00B 100.00%
2004-09-30 $0.00B $0.00B 100.00%
2004-06-30 $0.00B 0 0.00%
2004-03-31 $0.00B 0 0.00%
2003-12-31 $0.00B 0 0.00%
2003-09-30 $0.00B 0 0.00%
2003-06-30 $0.00B 0 0.00%
2003-03-31 $0.00B 0 0.00%
2002-09-30 $0.00B 0 0.00%
2002-06-30 $0.00B 0 0.00%
2001-12-31 $0.00B $0.00B 100.00%
2001-09-30 $0.00B $0.00B 100.00%
2001-06-30 $0.00B $0.00B 100.00%
2001-03-31 $0.00B 0 0.00%
2000-12-31 $0.00B 0 0.00%
2000-09-30 $0.00B 0 0.00%
2000-06-30 $0.00B 0 0.00%
2000-03-31 $0.00B 0 0.00%
1999-12-31 $0.00B 0 0.00%
1999-06-30 $0.00B 0 0.00%
1999-03-31 $0.00B 0 0.00%
1998-06-30 $0.00B 0 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.450B $0.139B
SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and treatment of serious infectious diseases, with an emphasis on products for biological warfare defense. SIGA believes that it is a leader in the development of pharmaceutical agents and vaccines to fight potential biowarfare pathogens. With broad technology platforms in both vaccines and antibiotics, SIGA's product development programs emphasize the increasingly serious problem of drug resistant bacteria. In addition to smallpox, SIGA has antiviral programs targeting other Category A pathogens, including arenaviruses, dengue virus, and the filoviruses.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.531B 30.59
Zoetis (ZTS) United States $52.936B 18.95
Takeda Pharmaceutical (TAK) Japan $44.579B 9.10
Daiichi Sankyo, - (DSNKY) Japan $41.884B 20.86
BeOne Medicines - (ONC) Switzerland $37.686B 199.80
Sandoz Group AG (SDZNY) Switzerland $30.065B 0.00
United Therapeutics (UTHR) United States $19.772B 17.40
Merck (MKKGY) Germany $16.918B 11.00
Summit Therapeutics (SMMT) United States $14.775B 0.00
Neurocrine Biosciences (NBIX) United States $14.686B 35.24
Shionogi (SGIOY) Japan $14.581B 13.39
IPSEN (IPSEY) France $12.599B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.298B 0.00
Ionis Pharmaceuticals (IONS) United States $11.735B 0.00
Orion OYJ (ORINY) Finland $9.625B 27.50
Corcept Therapeutics (CORT) United States $8.311B 89.78
Eisai (ESAIY) $8.236B 0.00
Stevanato Group S.p.A (STVN) Italy $7.320B 40.97
Grifols, S.A (GRFS) Spain $6.002B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.493B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.075B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.753B 17.84
Hypermarcas (HYPMY) Brazil $3.123B 23.48
Centessa Pharmaceuticals (CNTA) United Kingdom $3.018B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.839B 9.06
Dyne Therapeutics (DYN) United States $2.809B 0.00
Soleno Therapeutics (SLNO) United States $2.616B 0.00
Ocular Therapeutix (OCUL) United States $2.390B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.067B 24.50
Guardian Pharmacy Services (GRDN) United States $1.979B 38.11
Avadel Pharmaceuticals (AVDL) Ireland $1.828B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.522B 90.38
Ardelyx (ARDX) United States $1.489B 0.00
Harrow (HROW) United States $1.435B 88.04
Collegium Pharmaceutical (COLL) United States $1.417B 7.02
Amylyx Pharmaceuticals (AMLX) United States $1.393B 0.00
Xeris Biopharma Holdings (XERS) United States $1.234B 0.00
Nektar Therapeutics (NKTR) United States $1.205B 0.00
Oruka Therapeutics (ORKA) United States $1.171B 0.00
Enliven Therapeutics (ELVN) United States $1.163B 0.00
Relay Therapeutics (RLAY) United States $1.090B 0.00
Xencor (XNCR) United States $1.062B 0.00
Evotec AG (EVO) Germany $1.055B 0.00
Cronos Group (CRON) Canada $0.965B 0.00
Theravance Biopharma (TBPH) United States $0.932B 39.36
ARS Pharmaceuticals (SPRY) United States $0.867B 0.00
Organogenesis (ORGO) United States $0.825B 0.00
ProKidney (PROK) United States $0.824B 0.00
Savara (SVRA) United States $0.748B 0.00
Esperion Therapeutics (ESPR) United States $0.741B 0.00
Aquestive Therapeutics (AQST) United States $0.694B 0.00
Elite Pharmaceuticals (ELTP) United States $0.694B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.689B 6.15
Bioventus (BVS) United States $0.637B 13.05
4D Molecular Therapeutics (FDMT) United States $0.617B 0.00
KalVista Pharmaceuticals (KALV) United States $0.580B 0.00
Zevra Therapeutics (ZVRA) United States $0.531B 0.00
Lexeo Therapeutics (LXEO) United States $0.492B 0.00
Akebia Therapeutics (AKBA) United States $0.480B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.469B 11.11
Altimmune (ALT) United States $0.447B 0.00
Galectin Therapeutics (GALT) United States $0.355B 0.00
Nature's Sunshine Products (NATR) United States $0.350B 20.83
USANA Health Sciences (USNA) United States $0.348B 9.70
Lyell Immunopharma (LYEL) United States $0.331B 0.00
Aldeyra Therapeutics (ALDX) United States $0.315B 0.00
Korro Bio (KRRO) United States $0.308B 0.00
Larimar Therapeutics (LRMR) United States $0.300B 0.00
Pyxis Oncology (PYXS) United States $0.285B 0.00
Achieve Life Sciences (ACHV) Canada $0.254B 0.00
Aclaris Therapeutics (ACRS) United States $0.249B 0.00
Journey Medical (DERM) United States $0.238B 0.00
OmniAb (OABI) United States $0.232B 0.00
Heron Therapeutics (HRTX) United States $0.213B 0.00
AleAnna (ANNA) United States $0.210B 0.00
Protara Therapeutics (TARA) United States $0.207B 0.00
MediWound (MDWD) Israel $0.205B 0.00
Avalo Therapeutics (AVTX) United States $0.204B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.161B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.154B 0.00
Cassava Sciences (SAVA) United States $0.150B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.128B 0.00
Incannex Healthcare (IXHL) Australia $0.125B 0.00
Inhibikase Therapeutics (IKT) United States $0.122B 0.00
Avita Medical (RCEL) United States $0.121B 0.00
Context Therapeutics (CNTX) United States $0.109B 0.00
Relmada Therapeutics (RLMD) United States $0.109B 0.00
Surrozen (SRZN) United States $0.104B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Gain Therapeutics (GANX) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 35.00
Karyopharm Therapeutics (KPTI) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.090B 0.00
Assertio Holdings (ASRT) United States $0.089B 0.00
Dominari Holdings (DOMH) United States $0.087B 0.00
VAXART, INC (VXRT) United States $0.085B 0.00
Unicycive Therapeutics (UNCY) United States $0.085B 0.00
Metagenomi (MGX) United States $0.083B 0.00
Plus Therapeutics (PSTV) United States $0.078B 0.00
Prelude Therapeutics (PRLD) United States $0.076B 0.00
Lite Strategy (LITS) United States $0.074B 0.00
Nutriband (NTRB) United States $0.073B 0.00
PMV Pharmaceuticals (PMVP) United States $0.070B 0.00
Rafael Holdings (RFL) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.065B 0.00
BioNxt Solutions (BNXTF) Canada $0.063B 0.00
Talphera (TLPH) United States $0.060B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Fractyl Health (GUTS) United States $0.055B 0.00
Wellgistics Health (WGRX) United States $0.053B 0.00
ElectroCore (ECOR) United States $0.050B 0.00
Arch Biopartners (ACHFF) Canada $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Telomir Pharmaceuticals (TELO) United States $0.049B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Jupiter Neurosciences (JUNS) United States $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.043B 0.00
FibroGen (FGEN) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Inotiv (NOTV) United States $0.036B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
Liminatus Pharma (LIMN) United States $0.032B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.030B 25.00
Iterum Therapeutics (ITRM) Ireland $0.029B 0.00
Scienture Holdings (SCNX) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.025B 0.00
SCYNEXIS (SCYX) United States $0.025B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Vyome Holdings (HIND) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Mangoceuticals (MGRX) United States $0.018B 0.00
Heatwurx (PCSA) United States $0.018B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Ainos (AIMD) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
Traws Pharma (TRAW) United States $0.013B 0.02
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CDT Equity (CDT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 15.85
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00